Reading-based Kymira has secured £3.7M investment led by Nigel Wray and his company Euroblue, who are strong UK investors and passionate sports leaders. Nigel has large shares in London’s Saracens Rugby club, as well as being a former chairman of the club and a passionate sports collector.
Nigel said:“Kymira’s clothing already has a great reputation with some substantial sporting organisations across the world for their recovery, performance, injury risk mitigation and rehab work. What is maybe even more exciting is the E-textiles and medicinal potential in due course. That’s why we’re so pleased to become shareholders behind this really exciting company.”
The investment will build upon the company’s current commercial and international growth, bringing more advanced E-textile products onto the market to push the boundaries of limitations in sports.
To aid in this upscaling, Kymira has recruited Chris Hill – who headed up Business Development for Catapult Sports UK & Ireland – and Joe Boyle, respectively, who is VP Business Development for North America for sport. Chris and Joe’s help will commercialise the new Kymira technology and development of innovations for the market.
Tim Brownstone Founder and CEO of Kymira, said: “KYMIRA’s recent investment, led by Nigel Wray and Euroblue Investments has fuelled rapid growth for the business. With the growing successes [we have been] seeing in the UK, we are now making strides within the US market now as well. The appointment of our VP of Business Development for North America, Joseph Boyle, is the first major step. Alongside Chris Hill for EMEA, I know the Sales Development is in excellent hands.
“I am so excited to see what we can achieve over the coming years, and the impact that will have on the world, with our current and future technologies”
After becoming injured midway through his first season competing internationally, Tim started looking for a way that he could accelerate his rehabilitation. In doing so he found research published by NASA about how they used infrared light to grow plants quicker in space. This sparked an idea that the use of infrared light could stimulate human cell growth and accelerate cell performance and healing.
A product in its final stages of development is an e-textile for the elite professional sports market that will combine biometric data to review and optimise performance, training, and rehabilitation. This will be to the highest medical device quality, with KYMIRA® recently achieving the ISO 13485:2016 Wearable Technology Medical Device accreditation. This specifies requirements for a quality management system where an organisation demonstrates its ability to provide medical devices that meet customer requirements. This, says the company makes Kymira one of the first, potentially the first, in the wearable technology space to receive such a high level of certification.